What does this research mean for the field?

The use of CFTR modulators during pregnancy and breastfeeding presents complex ethical dilemmas due to the tension between maternal health benefits and potential fetal toxicity, highlighting an urgent need for further research to guide clinical decisions. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate ethical and clinical dilemmas regarding CFTR modulator use during pregnancy and lactation across distinct maternal-fetal scenarios.

August 27, 2026Pediatric Pulmonology

Ethical Considerations With CFTR Modulator Use in Pregnancy

View Full Paper

Ask AI

Bookmark

Authors

MSMegan Sheppard JMJohn Massie

Discussion

Member takes

Overview

Ethical review examines dilemmas surrounding CFTR modulator safety in pregnancy, highlighting the urgent need for structured guidance across varied maternal and fetal genetic scenarios.

Key Points

To evaluate ethical and clinical dilemmas regarding CFTR modulator use during pregnancy and lactation across distinct maternal-fetal scenarios.
Assessed ethical and clinical implications across four distinct maternal-fetal and lactation scenarios involving CFTR modulator treatment.
Evaluated the balance between preserving maternal health and mitigating potential fetal toxicity risks.
Pregnancy rates in individuals with cystic fibrosis have doubled following the introduction of CFTR modulators.
Clinicians and parents face ongoing ethical conflicts between maintaining maternal health and exposing fetuses or nursing infants to unknown drug toxicities.
Evidence regarding reproductive safety remains limited, highlighting an urgent need for targeted research to guide clinical decision-making.

Cite This Study

Sheppard et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea0110c91c1e92621f5d https://doi.org/10.1002/ppul.71806

View Full Paper

Ask AI

Bookmark

August 27, 2026Pediatric Pulmonology

Ethical Considerations With CFTR Modulator Use in Pregnancy

View Full Paper

Ask AI

Bookmark

Authors

MSMegan Sheppard JMJohn Massie

Discussion

Member takes

Overview

Ethical review examines dilemmas surrounding CFTR modulator safety in pregnancy, highlighting the urgent need for structured guidance across varied maternal and fetal genetic scenarios.

Key Points

To evaluate ethical and clinical dilemmas regarding CFTR modulator use during pregnancy and lactation across distinct maternal-fetal scenarios.
Assessed ethical and clinical implications across four distinct maternal-fetal and lactation scenarios involving CFTR modulator treatment.
Evaluated the balance between preserving maternal health and mitigating potential fetal toxicity risks.
Pregnancy rates in individuals with cystic fibrosis have doubled following the introduction of CFTR modulators.
Clinicians and parents face ongoing ethical conflicts between maintaining maternal health and exposing fetuses or nursing infants to unknown drug toxicities.
Evidence regarding reproductive safety remains limited, highlighting an urgent need for targeted research to guide clinical decision-making.

Cite This Study

Sheppard et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea0110c91c1e92621f5d https://doi.org/10.1002/ppul.71806

View Full Paper

Ask AI

Bookmark